RxDoctor Payments Data

Bradford Bobrin, MD

Psychiatry · Reading, PANPI 1255365367

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $21,930 of the $24,305 with a category attached, or 90.2%. Alkermes, Inc. accounts for 91.7% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2020 at $8,890 and has fallen 99.8% since, to $19 in 2025. Among psychiatry clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,305in general payments, 2019–2025

Across 133 payments — averaging $182.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$22K
  • AbbVie$575
  • Johnson & Johnson$288
  • Corium, LLC$218
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$199
  • Otsuka America Pharmaceutical, Inc.$163
  • plus $579 from 8 others

What the payments were for

  • Speaking & faculty fees$21,93090%
  • Food & beverage$2,31210%
  • Education$640%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,305 in reported general payments places this provider in the 95th percentile of 1,838 psychiatry providers in Pennsylvania.

See all psychiatry providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$52,857
Medicare patients
77
Services billed
608

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Olanzapine OdtOlanzapine24$3,245
Gabapentin18$438
Divalproex Sodium ErDivalproex Sodium12$351
Albuterol Sulfate HfaAlbuterol Sulfate11$339
Trazodone Hcl51$172
Clonazepam15$165
Mirtazapine11$145
Atorvastatin Calcium34$136
Quetiapine Fumarate14$100
Pantoprazole Sodium15$97
Lorazepam13$96
Levothyroxine Sodium14$74
Amlodipine Besylate11$74
Risperidone13$55

Paid to pharmacies, not to this prescriber.

Other psychiatry in Reading

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →